Sign in
CompletedNo phase

Neurophysiology of Fibromyalgia

Key facts

Who runs it
McMaster University
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
36 people enrolled
Started
1 Feb 2024
Ended
31 Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Active Controlled Pulse Parameter Transcranial Magnetic Stimulation (cTMS)
  • Sham Controlled Pulse Parameter Transcranial Magnetic Stimulation (cTMS)
Record updated
4 June 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • 18-65 years old

Who cannot take part

  • contraindications to TMS
  • chronic pain associated with diagnoses other than fibromyalgia

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Fibromyalgia is a syndrome associated with fatigue and chronic pain, leading to significant physical limitations and impaired quality of life. There are several challenges that complicate the diagnosis and management of fibromyalgia. The etiology is not well defined, as there are several proposed factors that may trigger the genesis of pain in fibromyalgia including physical and/or emotional life stressors, and genetic predispositions involving neuromodulator pathways. Chronic pain in fibromyalgia arises in the absence of tissue pathology, and consequently a lack of consensus on reliable diagnostic criteria. Understanding the neurophysiology of fibromyalgia would aid in the discovery of objective biomarkers for diagnosis. Therefore, the goals of this study are to:

Read full original descriptionShow less

1. Compare the neurophysiological responses in fibromyalgia compared to healthy controls. 2. Determine whether a two-week cTMS protocol will alter pain in individuals with fibromyalgia.

The 2 groups in the trial

  • Active cTMSExisting treatment, for comparison

    Controlled Pulse Parameter Transcranial Magnetic Stimulation (cTMS) will be delivered at 10 Hz, 2000 pulses targeting the hand representation of the left primary motor cortex. cTMS delivery will require \~11 min to complete. In Experiment 1, this intervention will be performed for 1 session (\~11min). In Experiment 2, this intervention will be performed approximately 5 days per week for 2 weeks. In addition, participants will experience their standard medical care.

    Treatment: Active Controlled Pulse Parameter Transcranial Magnetic Stimulation (cTMS)

  • Sham cTMSSham treatment, for comparison

    Sham cTMS will be delivered at as a placebo control. It is important to note that from the participant perspective, the sham stimulation will feel and sound identical to active cTMS. In Experiment 2, this intervention will be performed approximately 5 days per week for 2 weeks. In addition, participants will experience their standard medical care.

    Treatment: Sham Controlled Pulse Parameter Transcranial Magnetic Stimulation (cTMS)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Investigating the Neurobiological Contributions to Pain in Patients With Fibromyalgia
Record updated
4 June 2026